Novel Aptamers for the Reactivation of Latent HIV
CONCLUSION: This study demonstrated the reactivation of latent HIV by aptamers that act via the NF-κβ pathway. Although the effect was modest and unlikely to be of clinical benefit, future studies are warranted to explore ways of enhancing reactivation.PMID:37881079 | DOI:10.2174/011570162X248488230926045852 (Source: Current HIV Research)
Source: Current HIV Research - October 26, 2023 Category: Infectious Diseases Authors: William Serumula Bongani Nkambule Raveen Parboosing Source Type: research
Novel Aptamers for the Reactivation of Latent HIV
CONCLUSION: This study demonstrated the reactivation of latent HIV by aptamers that act via the NF-κβ pathway. Although the effect was modest and unlikely to be of clinical benefit, future studies are warranted to explore ways of enhancing reactivation.PMID:37881079 | DOI:10.2174/011570162X248488230926045852 (Source: Current HIV Research)
Source: Current HIV Research - October 26, 2023 Category: Infectious Diseases Authors: William Serumula Bongani Nkambule Raveen Parboosing Source Type: research
Novel Aptamers for the Reactivation of Latent HIV
CONCLUSION: This study demonstrated the reactivation of latent HIV by aptamers that act via the NF-κβ pathway. Although the effect was modest and unlikely to be of clinical benefit, future studies are warranted to explore ways of enhancing reactivation.PMID:37881079 | DOI:10.2174/011570162X248488230926045852 (Source: Current HIV Research)
Source: Current HIV Research - October 26, 2023 Category: Infectious Diseases Authors: William Serumula Bongani Nkambule Raveen Parboosing Source Type: research
Novel Aptamers for the Reactivation of Latent HIV
CONCLUSION: This study demonstrated the reactivation of latent HIV by aptamers that act via the NF-κβ pathway. Although the effect was modest and unlikely to be of clinical benefit, future studies are warranted to explore ways of enhancing reactivation.PMID:37881079 | DOI:10.2174/011570162X248488230926045852 (Source: Current HIV Research)
Source: Current HIV Research - October 26, 2023 Category: Infectious Diseases Authors: William Serumula Bongani Nkambule Raveen Parboosing Source Type: research
Novel Aptamers for the Reactivation of Latent HIV
CONCLUSION: This study demonstrated the reactivation of latent HIV by aptamers that act via the NF-κβ pathway. Although the effect was modest and unlikely to be of clinical benefit, future studies are warranted to explore ways of enhancing reactivation.PMID:37881079 | DOI:10.2174/011570162X248488230926045852 (Source: Current HIV Research)
Source: Current HIV Research - October 26, 2023 Category: Infectious Diseases Authors: William Serumula Bongani Nkambule Raveen Parboosing Source Type: research
Novel Aptamers for the Reactivation of Latent HIV
CONCLUSION: This study demonstrated the reactivation of latent HIV by aptamers that act via the NF-κβ pathway. Although the effect was modest and unlikely to be of clinical benefit, future studies are warranted to explore ways of enhancing reactivation.PMID:37881079 | DOI:10.2174/011570162X248488230926045852 (Source: Current HIV Research)
Source: Current HIV Research - October 26, 2023 Category: Infectious Diseases Authors: William Serumula Bongani Nkambule Raveen Parboosing Source Type: research
Novel Aptamers for the Reactivation of Latent HIV
CONCLUSION: This study demonstrated the reactivation of latent HIV by aptamers that act via the NF-κβ pathway. Although the effect was modest and unlikely to be of clinical benefit, future studies are warranted to explore ways of enhancing reactivation.PMID:37881079 | DOI:10.2174/011570162X248488230926045852 (Source: Current HIV Research)
Source: Current HIV Research - October 26, 2023 Category: Infectious Diseases Authors: William Serumula Bongani Nkambule Raveen Parboosing Source Type: research
Novel Aptamers for the Reactivation of Latent HIV
CONCLUSION: This study demonstrated the reactivation of latent HIV by aptamers that act via the NF-κβ pathway. Although the effect was modest and unlikely to be of clinical benefit, future studies are warranted to explore ways of enhancing reactivation.PMID:37881079 | DOI:10.2174/011570162X248488230926045852 (Source: Current HIV Research)
Source: Current HIV Research - October 26, 2023 Category: Infectious Diseases Authors: William Serumula Bongani Nkambule Raveen Parboosing Source Type: research
Novel Aptamers for the Reactivation of Latent HIV
CONCLUSION: This study demonstrated the reactivation of latent HIV by aptamers that act via the NF-κβ pathway. Although the effect was modest and unlikely to be of clinical benefit, future studies are warranted to explore ways of enhancing reactivation.PMID:37881079 | DOI:10.2174/011570162X248488230926045852 (Source: Current HIV Research)
Source: Current HIV Research - October 26, 2023 Category: Infectious Diseases Authors: William Serumula Bongani Nkambule Raveen Parboosing Source Type: research
Novel Aptamers for the Reactivation of Latent HIV
CONCLUSION: This study demonstrated the reactivation of latent HIV by aptamers that act via the NF-κβ pathway. Although the effect was modest and unlikely to be of clinical benefit, future studies are warranted to explore ways of enhancing reactivation.PMID:37881079 | DOI:10.2174/011570162X248488230926045852 (Source: Current HIV Research)
Source: Current HIV Research - October 26, 2023 Category: Infectious Diseases Authors: William Serumula Bongani Nkambule Raveen Parboosing Source Type: research
Coex ıstence of Cryptococcal Fungemıa and Pneumocystıs Jırovecıı Pneumonıa ın an HIV-ınfected Patıent: A Case Report
CONCLUSION: While the incidence of opportunistic infections has decreased with antiretroviral therapy (ART), it remains a problem in patients who are unaware of being infected with HIV or who fail ART or refuse treatment. High fungal burden, advanced age, low CD4+ cell count, and being underweight are risk factors for mortality in HIV-positive patients. Our case was a cachectic patient with a CD4 count of 7 cells/mm3 . Despite the early and effective treatment, the course was fatal.PMID:37877566 | DOI:10.2174/011570162X254084231016192302 (Source: Current HIV Research)
Source: Current HIV Research - October 25, 2023 Category: Infectious Diseases Authors: Tuba Tatli Ki ş S üleyman Yıldırım Can Bi çmen Nur Y ücel Cenk K ıraklı Source Type: research
Coex ıstence of Cryptococcal Fungemıa and Pneumocystıs Jırovecıı Pneumonıa ın an HIV-ınfected Patıent: A Case Report
CONCLUSION: While the incidence of opportunistic infections has decreased with antiretroviral therapy (ART), it remains a problem in patients who are unaware of being infected with HIV or who fail ART or refuse treatment. High fungal burden, advanced age, low CD4+ cell count, and being underweight are risk factors for mortality in HIV-positive patients. Our case was a cachectic patient with a CD4 count of 7 cells/mm3 . Despite the early and effective treatment, the course was fatal.PMID:37877566 | DOI:10.2174/011570162X254084231016192302 (Source: Current HIV Research)
Source: Current HIV Research - October 25, 2023 Category: Infectious Diseases Authors: Tuba Tatli Ki ş S üleyman Yıldırım Can Bi çmen Nur Y ücel Cenk K ıraklı Source Type: research
Prevalence of Toxoplasma gondii in HIV-Infected Individuals in Iran: A Systematic Review and Meta-Analysis
CONCLUSION: According to the results of this study, it can be clearly understood that a large population of HIV patients living in Iran have toxoplasmosis. Therefore, due to the high susceptibility of these groups to toxoplasmosis, healthcare professionals must consider measures such as training in the ways of transmission and prevention of the infection to this high-risk group in order to reduce the risk of infection.PMID:37873950 | DOI:10.2174/011570162X244384230920033134 (Source: Current HIV Research)
Source: Current HIV Research - October 24, 2023 Category: Infectious Diseases Authors: Pegah Shakib Masoud Behzadifar Hossein Mahmoudvand Sara Larki Hamed Kalani Masoomeh Zivdari Omid Mardanshah Kourosh Cheraghipour Source Type: research
Prevalence of Toxoplasma gondii in HIV-Infected Individuals in Iran: A Systematic Review and Meta-Analysis
CONCLUSION: According to the results of this study, it can be clearly understood that a large population of HIV patients living in Iran have toxoplasmosis. Therefore, due to the high susceptibility of these groups to toxoplasmosis, healthcare professionals must consider measures such as training in the ways of transmission and prevention of the infection to this high-risk group in order to reduce the risk of infection.PMID:37873950 | DOI:10.2174/011570162X244384230920033134 (Source: Current HIV Research)
Source: Current HIV Research - October 24, 2023 Category: Infectious Diseases Authors: Pegah Shakib Masoud Behzadifar Hossein Mahmoudvand Sara Larki Hamed Kalani Masoomeh Zivdari Omid Mardanshah Kourosh Cheraghipour Source Type: research
Differential Diagnosis or Etiology: A Case Report on Amyotrophic Lateral Sclerosis-like Neuropathy Associated with HIV Infection
CONCLUSION: After a short follow-up and viral load cleansing, neurological stabilization was achieved.PMID:37711011 | DOI:10.2174/1570162X21666230914104220 (Source: Current HIV Research)
Source: Current HIV Research - September 15, 2023 Category: Infectious Diseases Authors: Renato Barradas Rodrigues Marco Orsini Sofia Vieira Neves Wladimir Bocca Vieira de Rezende Pinto Ant ônio Marcos da Silva Catarino Daniel Antunes Pereira Acary Souza Bulle Oliveira Source Type: research
